{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:27:01Z","timestamp":1790303221899,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To describe the use of nuclear medicine cerebral perfusion studies as an ancillary test for brain death\/death by neurologic criteria (BD\/DNC) in infants aged under 1 year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective case series.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Single-center, quaternary, academic children\u2019s hospital in the United States.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients younger than 1 year of age whose evaluation for BD\/DNC included a nuclear medicine cerebral perfusion study as an ancillary test, 2005\u20132022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Ten infants were identified from local databases. Mechanisms of brain injury included hypoxic-ischemic injury (8\/10), traumatic brain injury (1\/10), and intracranial hemorrhage (1\/10). Testable components of the first BD\/DNC examination were consistent with BD\/DNC in all patients. Apnea testing was consistent with BD\/DNC in 5 of 10 patients and deferred or terminated prematurely in 5 of 10 patients. All patients underwent ancillary testing with a nuclear medicine scan to assess cerebral perfusion using <jats:sup>99m<\/jats:sup>Tc-ethyl cysteinate dimer (<jats:sup>99m<\/jats:sup>Tc-ECD). Indications were inability to complete the apnea test (5\/10), presence of a confounder to the clinical examination (3\/10), and clinician discretion (2\/10). Nine studies were consistent with BD\/DNC. The patient whose ancillary test was inconsistent with BD\/DNC had their examination limited by the inability to assess the pupillary reflex and subsequently underwent withdrawal of life-sustaining technology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Radionuclide cerebral perfusion studies using <jats:sup>99m<\/jats:sup>Tc-ECD were used in our setting to support the determination of BD\/DNC in infants aged younger than 1 year of age.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003596","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T15:00:51Z","timestamp":1733324451000},"page":"1089-1095","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Nuclear Medicine Cerebral Perfusion Studies as an Ancillary Test to Support Evaluation of Brain Death\/Death by Neurologic Criteria: Single-Center Experience in Infants, 2005\u20132022*"],"prefix":"10.1097","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1960-2979","authenticated-orcid":false,"given":"Ashley M.","family":"Bach","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole K.","family":"McKinnon","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Kirschen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.0000000000207740","article-title":"Pediatric and adult brain death\/death by neurologic criteria consensus guideline: Report of the AAN guidelines subcommittee, AAP, CNS, and SCCM.","volume":"101","author":"Greer","year":"2023","journal-title":"Neurology"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/CCM.0b013e31821f0d4f","article-title":"Guidelines for the determination of brain death in infants and children: An update of the 1987 Task Force recommendations.","volume":"39","author":"Nakagawa","year":"2011","journal-title":"Crit Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pediatrneurol.2020.01.019","article-title":"Incidence and indications for ancillary testing in the determination of death by neurological criteria in children.","volume":"106","author":"Kirschen","year":"2020","journal-title":"Pediatr Neurol"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/0883073817724697","article-title":"Use of ancillary tests when determining brain death in pediatric patients in the United States.","volume":"32","author":"Lewis","year":"2017","journal-title":"J Child Neurol"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jama.2020.11586","article-title":"Determination of brain death\/death by neurologic criteria: The world brain death project.","volume":"324","author":"Greer","year":"2020","journal-title":"JAMA"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12630-023-02418-1","article-title":"Ancillary investigations for death determination in infants and children: A systematic review and meta-analysis.","volume":"70","author":"McKinnon","year":"2023","journal-title":"Can J Anaesth"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s12630-023-02419-0","article-title":"Radionuclide scintigraphy as an ancillary test for death determination in infants under two months of age.","volume":"70","author":"McKinnon","year":"2023","journal-title":"Can J Anesth"},{"key":"R8-20250502","article-title":"The diagnosis of death by neurological criteria in infants less than two months old.","year":"2015"},{"key":"R9-20250502","first-page":"15N","article-title":"2016 update of the North American consensus guidelines for pediatric administered radiopharmaceutical activities.","volume":"57","author":"Treves","year":"2016","journal-title":"J Nucl Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0037-1604015","article-title":"Ancillary studies in evaluating pediatric brain death.","volume":"6","author":"Henderson","year":"2017","journal-title":"J Pediatr Intensive Care"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15844\/pedneurbriefs-34-26","article-title":"Ancillary tests for death by neurologic criteria in children.","volume":"34","author":"Mayne","year":"2020","journal-title":"Pediatr Neurol Briefs"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12630-023-02426-1","article-title":"Diagnostic accuracy of ancillary tests for death by neurologic criteria: A systematic review and meta-analysis.","volume":"70","author":"Neves Briard","year":"2023","journal-title":"Can J Anesth"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s12630-023-02422-5","article-title":"Knowledge gaps in the definition and determination of death.","volume":"70","author":"Maitre","year":"2023","journal-title":"Can J Anaesth"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0885066609355388","article-title":"Specificity of radionuclide brain blood flow testing in brain death: Case report and review.","volume":"25","author":"Joffe","year":"2010","journal-title":"J Intensive Care Med"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/08830738221047668","article-title":"Impact of the updated guideline for pediatric brain death determination on current practice.","volume":"37","author":"Krawiec","year":"2022","journal-title":"J Child Neurol"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12630-023-02431-4","article-title":"A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: A 2023 clinical practice guideline.","volume":"70","author":"Shemie","year":"2023","journal-title":"Can J Anaesth"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12630-023-02420-7","article-title":"Ancillary radionuclide perfusion studies in the determination of death by neurologic criteria: methods, interpretation, and lexicon\u2014a user guide for the clinician.","volume":"70","author":"Zuckier","year":"2023","journal-title":"Can J Anaesth"},{"key":"R19-20250502","first-page":"197","article-title":"Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes.","volume":"29","author":"Koslowsky","year":"2001","journal-title":"J Nucl Med Technol"},{"key":"R20-20250502","first-page":"480","article-title":"Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.","volume":"33","author":"L\u00e9veill\u00e9","year":"1992","journal-title":"J Nucl Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:02:29Z","timestamp":1746205349000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003596","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}